TAKARA BIO INC. Logo

TAKARA BIO INC.

Provides life science research tools, gene therapies, and CDMO services for improving human health.

4974 | T

Overview

Corporate Details

ISIN(s):
JP3460200003
LEI:
Country:
Japan
Address:
草津市野路東七丁目4番38号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Takara Bio Inc. is a global biotechnology company dedicated to improving human health through innovative life science research tools and gene therapies. The company supplies a comprehensive portfolio of reagents, kits, instruments, and services to researchers focused on gene discovery, regulation, and function. Its offerings support a wide range of applications, including single-cell analysis, sequencing, immune profiling, and stem cell research. Additionally, Takara Bio is a key player in the development of cutting-edge medical technologies, focusing on gene and cell therapies for cancer and other diseases. The company also provides contract development and manufacturing (CDMO) services, supporting partners in the production of therapeutic products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-12 03:15
Registration Form
確認書
Japanese 8.1 KB
2025-11-12 03:13
Interim / Quarterly Report
半期報告書-第24期(2025/04/01-2026/03/31)
Japanese 191.8 KB
2025-06-30 02:46
AGM Information
臨時報告書
Japanese 27.5 KB
2025-06-20 07:27
Registration Form
確認書
Japanese 8.1 KB
2025-06-20 07:26
Governance Information
内部統制報告書-第23期(2024/04/01-2025/03/31)
Japanese 23.6 KB
2025-06-20 07:24
Annual Report
有価証券報告書-第23期(2024/04/01-2025/03/31)
Japanese 1.7 MB
2025-05-13 09:11
Board/Management Information
臨時報告書
Japanese 21.8 KB
2024-11-11 02:37
Regulatory Filings
確認書
Japanese 8.1 KB
2024-11-11 02:36
Interim / Quarterly Report
半期報告書-第23期(2024/04/01-2025/03/31)
Japanese 167.8 KB
2024-07-01 04:07
AGM Information
訂正臨時報告書
Japanese 36.9 KB
2024-06-28 04:30
AGM Information
臨時報告書
Japanese 27.3 KB
2024-06-27 06:14
Governance Information
内部統制報告書-第22期(2023/04/01-2024/03/31)
Japanese 22.7 KB
2024-06-27 06:13
Registration Form
確認書
Japanese 8.1 KB
2024-06-27 06:12
Annual Report
有価証券報告書-第22期(2023/04/01-2024/03/31)
Japanese 1.8 MB
2024-02-14 07:42
Report Publication Announcement
確認書
Japanese 8.1 KB

Automate Your Workflow. Get a real-time feed of all TAKARA BIO INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for TAKARA BIO INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for TAKARA BIO INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Develops cord blood stem cell therapies for osteoarthritis & infant lung disease, plus banking.
South Korea
078160
Medivir Logo
Clinical-stage pharma firm developing tumor-directed therapies for high-need cancer patients.
Sweden
MVIR
MediWound Ltd. Logo
Develops enzymatic therapies for non-surgical tissue repair in burns and chronic wounds.
United States of America
MDWD
Develops biomarker-based precision therapies for oncology and other incurable diseases.
South Korea
235980
Medrx Co.,Ltd. Logo
Develops and licenses transdermal drug delivery systems for the pharmaceutical industry.
Japan
4586
Medy-Tox Inc. Logo
Develops and markets botulinum toxins and dermal fillers for global aesthetic & therapeutic use.
South Korea
086900
MeiraGTx Holdings plc Logo
Develops genetic medicines for eye, salivary gland, and CNS disorders using gene regulation tech.
United States of America
MGTX
Mendus Logo
Developing immunotherapies using dendritic cells to prevent cancer recurrence and improve survival.
Sweden
IMMU
Merck & Co., Inc. Logo
A global biopharma developing innovative medicines, vaccines, and animal health products.
United States of America
MRK
Mereo BioPharma Group plc Logo
A clinical-stage biopharma developing and commercializing novel therapies for rare diseases.
United States of America
MREO

Talk to a Data Expert

Have a question? We'll get back to you promptly.